Caricamento...
Direct Acting Antiviral Treatment for Patients with End-Stage Kidney Disease with Acute HCV Infection
BACKGROUND: Hepatitis C virus (HCV) infection is a public health problem. Such an infection is prevalent and aggressive in patients with end-stage kidney disease (ESKD). The efficacy and the safety of direct-acting antivirus (DAA) in patients with acute HCV and ESKD are under investigation. The aim...
Salvato in:
| Pubblicato in: | Mediterr J Hematol Infect Dis |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Università Cattolica del Sacro Cuore
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6548205/ https://ncbi.nlm.nih.gov/pubmed/31205638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2019.034 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|